Spring 2013 : Mexico, Texas institutions wage war on tobacco
Mexico, Texas institutions wage war on tobacco
Collaboration engages moon shot cancer prevention and control platform
MD Anderson, the National Institute of Cancer of the United Mexican States, and the Commission of National Institutes and High Specialty Hospitals recently joined forces in a first-of-its-kind agreement to develop prevention and control programs to reduce tobacco use in the United States and Mexico. The goal is to create a comprehensive evidence-based smoking and tobacco-cessation campaign targeting Mexican and Mexican-American youth.
The Mexico and Texas Tobacco Control Initiative will focus on legislative and policy initiatives and collaborate on services and programs to be used in neighborhoods, schools and workplaces. It’s the first flagship project from the cancer prevention and control platform, a major emphasis of MD Anderson’s Moon Shots Program, says Ronald DePinho, M.D., president.
“This agreement will advance tobacco prevention and cessation efforts drawing on the experience and expertise of both partners, while providing new opportunities to develop more progressive programs, services, policies and initiatives for both countries,” says DePinho. “Although our initial approach is to start with Texas and Mexico, we want to develop a model that will scale for the United States and other Spanish-speaking countries around the world.”
More Stories From Promise

A message from Dr. DePinho
A word from the president

A bright future for philanthropy
Young donors reflect the heart of giving

Seminar offers a glimpse at the moon shot play book
Guests encouraged to be part of the game plan

Leading gifts lay groundwork for Moon Shots Program
MD Anderson's Moon Shots Program, an aggressive, milestone-driven effort
initially targeting eight cancers, relies on private philanthropy as a
crucial source of funding.

Beating the odds
It's been said that the early bird catches the worm. The old English
proverb, stressing the 15th-century virtues of hard work and
perseverance, is still a mantra for modern times. Just ask 21st century
MD Anderson researchers, clinicians, surgeons and scientists intent on
more effectively preventing, detecting and treating cancer - the earlier
the better.

Triumph Over Kid Cancer Foundation
Teen on a mission to 'make it better' for others

iPromise
In 2001, Anthony Pistone of West Palm Beach, Fla. received a diagnosis
of chronic lymphocytic leukemia. His wife, Lorie, reflects on their
cancer journey at MD Anderson and finds a silver lining to share.

Survivors Say
John Webb retired in 1996 as president of Exxon Chemical Americas. He is
a three-time cancer survivor and longtime MD Anderson supporter. He and
his wife, Francine, live in Austin

AT&T donation helps teens stay connected
A group of 18 MD Anderson cancer patients and survivors formed imPACT
(Patient Advisory Council for Teens) last fall, partnering with hospital
staff in the decision-making process and working together on patient
care projects.

Blackjack players hit it big in fight against cancer
The Hampton Post Oak Blackjack Club recently donated $500 to MD Anderson

Motorcycle group revs up brain cancer research
Sam's Jam honors late MD Anderson neurosurgeon

Unconventional fundraising idea rocks
Rod Ryan Show t-shirt sales benefit cancer research

San Antonio A Conversation With a Living Legend®
Former President George W. Bush honored

Santa's Elves spread holiday joy
Annual event benefits pediatric programs

BISH Foundation creates hope from loss
Inspiration spurs fight against ovarian cancer

Mulvas fund lifesaving melanoma research
Conference center named in couple's honor

Safeway supports groundbreaking breast cancer research
I-SPY 2 trial aims to speed new therapies to clinic

A new approach to Alzheimer's
Belfer Family Foundation's $25 million gift establishes unique research consortium

MD Anderson, GlaxoSmithKline working on cancer immune therapy in $335M deal
MD Anderson and the global pharmaceutical company GlaxoSmithKline (GSK)
will jointly conduct research leading to new therapeutic antibodies that
help the immune system fight cancer.

MD Anderson kudos at National Philanthropy Day
The Association of Fundraising Professionals, Greater Houston Chapter,
recognizes organizations and people who contribute time, talents,
financial support and other resources to their community.

Depression, stress key factors in bladder cancer outcomes
Recent MD Anderson research reveals that depression and certain
age-related biomarkers could affect a bladder cancer patient's disease
progression and likelihood of survival.

Project to sort cancer-causing cellular chaos wins innovator award
Nicholas Navin, Ph.D., receives Damon Runyon-Rachleff Innovation Award

Stress triggers signaling pathway that leads to spread of ovarian cancer
MD Anderson scientists have discovered the signaling pathway whereby a
master regulator of cancer cell proteins - known as Src - leads to
ovarian cancer progression when exposed to stress hormones.

Breast cancer patients benefit from qigong
An ancient Chinese practice could make life better for women undergoing
treatment for breast cancer.